PL3356329T3 - Sposób wytwarzania kwasu 1-(4-metanosulfonylo-2-trifluorometylobenzylo)-2-metylo-1h-pirolo[2,3-b]pirydyn-3-ylooctowego - Google Patents
Sposób wytwarzania kwasu 1-(4-metanosulfonylo-2-trifluorometylobenzylo)-2-metylo-1h-pirolo[2,3-b]pirydyn-3-ylooctowegoInfo
- Publication number
- PL3356329T3 PL3356329T3 PL16775340T PL16775340T PL3356329T3 PL 3356329 T3 PL3356329 T3 PL 3356329T3 PL 16775340 T PL16775340 T PL 16775340T PL 16775340 T PL16775340 T PL 16775340T PL 3356329 T3 PL3356329 T3 PL 3356329T3
- Authority
- PL
- Poland
- Prior art keywords
- pyrrolo
- methanesulfonyl
- pyridin
- trifluoromethyl
- benzyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2015091024 | 2015-09-29 | ||
| PCT/IB2016/055777 WO2017056001A1 (en) | 2015-09-29 | 2016-09-27 | Process for preparing 1-(4-methanesulfonyl-2-trifluoromethyl-benzyl)-2-methyl-1h-pyrrolo [2,3-b]pyridin-3-yl-acetic acid |
| EP16775340.9A EP3356329B1 (en) | 2015-09-29 | 2016-09-27 | Process for preparing 1-(4-methanesulfonyl-2-trifluoromethyl-benzyl)-2-methyl-1h-pyrrolo [2,3-b]pyridin-3-yl-acetic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3356329T3 true PL3356329T3 (pl) | 2020-10-19 |
Family
ID=57047260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16775340T PL3356329T3 (pl) | 2015-09-29 | 2016-09-27 | Sposób wytwarzania kwasu 1-(4-metanosulfonylo-2-trifluorometylobenzylo)-2-metylo-1h-pirolo[2,3-b]pirydyn-3-ylooctowego |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US10508110B2 (pl) |
| EP (1) | EP3356329B1 (pl) |
| JP (1) | JP6839715B2 (pl) |
| KR (1) | KR20180058724A (pl) |
| CN (1) | CN108137503B (pl) |
| AR (1) | AR106195A1 (pl) |
| AU (2) | AU2016330264A1 (pl) |
| CA (1) | CA2998278A1 (pl) |
| DK (1) | DK3356329T3 (pl) |
| ES (1) | ES2805307T3 (pl) |
| HK (1) | HK1250713A1 (pl) |
| HU (1) | HUE049566T2 (pl) |
| IL (1) | IL257558B (pl) |
| JO (1) | JO3712B1 (pl) |
| PL (1) | PL3356329T3 (pl) |
| PT (1) | PT3356329T (pl) |
| RU (1) | RU2744976C1 (pl) |
| SI (1) | SI3356329T1 (pl) |
| TW (1) | TWI724031B (pl) |
| WO (1) | WO2017056001A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190223A1 (ar) * | 2017-04-01 | 2019-09-26 | Novartis Ag | عملية لتحضير حمض 1-(4- ميثان سلفونيل -2- تراي فلورو ميثيل - بنزيل)-2- ميثيل -1h- بيرولو [2، 3-b] بيريدين -3- يل- أسيتيك |
| WO2019011337A1 (zh) * | 2017-07-14 | 2019-01-17 | 苏州科睿思制药有限公司 | Qaw-039的晶型及其制备方法和用途 |
| CN110467612B (zh) * | 2018-05-09 | 2020-09-25 | 新发药业有限公司 | 一种前列腺素d2受体抑制剂化合物的简便制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0413619D0 (en) * | 2004-06-17 | 2004-07-21 | Novartis Ag | Organic compounds |
| MY144903A (en) * | 2004-06-17 | 2011-11-30 | Novartis Ag | Pyrrolopyridine derivatives and their use as crth2 antagonists |
| GB0525337D0 (en) * | 2005-12-13 | 2006-01-18 | Novartis Ag | Organic compounds |
| EP2197438B1 (en) * | 2007-10-10 | 2015-07-15 | Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | Heterocyclic compounds as crth2 receptor antagonists |
| SG11201500883YA (en) * | 2012-08-07 | 2015-04-29 | Aurigene Discovery Tech Ltd | 5-(1H-PYRAZOL-4-YL)-1H-PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS KINASE INHIBITORS |
-
2016
- 2016-09-27 US US15/763,562 patent/US10508110B2/en not_active Expired - Fee Related
- 2016-09-27 EP EP16775340.9A patent/EP3356329B1/en active Active
- 2016-09-27 SI SI201630838T patent/SI3356329T1/sl unknown
- 2016-09-27 KR KR1020187008435A patent/KR20180058724A/ko not_active Application Discontinuation
- 2016-09-27 RU RU2018115689A patent/RU2744976C1/ru active
- 2016-09-27 PT PT167753409T patent/PT3356329T/pt unknown
- 2016-09-27 HU HUE16775340A patent/HUE049566T2/hu unknown
- 2016-09-27 CA CA2998278A patent/CA2998278A1/en not_active Abandoned
- 2016-09-27 WO PCT/IB2016/055777 patent/WO2017056001A1/en active Application Filing
- 2016-09-27 JP JP2018535920A patent/JP6839715B2/ja active Active
- 2016-09-27 CN CN201680056743.8A patent/CN108137503B/zh not_active Expired - Fee Related
- 2016-09-27 ES ES16775340T patent/ES2805307T3/es active Active
- 2016-09-27 DK DK16775340.9T patent/DK3356329T3/da active
- 2016-09-27 PL PL16775340T patent/PL3356329T3/pl unknown
- 2016-09-27 AU AU2016330264A patent/AU2016330264A1/en not_active Abandoned
- 2016-09-29 AR ARP160102980A patent/AR106195A1/es unknown
- 2016-09-29 JO JOP/2016/0213A patent/JO3712B1/ar active
- 2016-09-29 TW TW105131422A patent/TWI724031B/zh not_active IP Right Cessation
-
2018
- 2018-02-15 IL IL257558A patent/IL257558B/en active IP Right Grant
- 2018-08-08 HK HK18110170.1A patent/HK1250713A1/zh unknown
-
2019
- 2019-10-22 AU AU2019253796A patent/AU2019253796B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018535248A (ja) | 2018-11-29 |
| PT3356329T (pt) | 2020-07-15 |
| US20180273530A1 (en) | 2018-09-27 |
| TWI724031B (zh) | 2021-04-11 |
| JP6839715B2 (ja) | 2021-03-10 |
| US10508110B2 (en) | 2019-12-17 |
| AU2016330264A1 (en) | 2018-03-22 |
| CA2998278A1 (en) | 2017-04-06 |
| DK3356329T3 (da) | 2020-07-13 |
| TW201718502A (zh) | 2017-06-01 |
| RU2744976C1 (ru) | 2021-03-17 |
| IL257558B (en) | 2021-01-31 |
| SI3356329T1 (sl) | 2020-08-31 |
| EP3356329B1 (en) | 2020-04-15 |
| IL257558A (en) | 2018-04-30 |
| ES2805307T3 (es) | 2021-02-11 |
| WO2017056001A1 (en) | 2017-04-06 |
| JO3712B1 (ar) | 2021-01-31 |
| CN108137503B (zh) | 2021-06-15 |
| HUE049566T2 (hu) | 2020-09-28 |
| AU2019253796A1 (en) | 2019-11-14 |
| HK1250713A1 (zh) | 2019-01-11 |
| KR20180058724A (ko) | 2018-06-01 |
| EP3356329A1 (en) | 2018-08-08 |
| AU2019253796B2 (en) | 2021-01-21 |
| AR106195A1 (es) | 2017-12-20 |
| CN108137503A (zh) | 2018-06-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201708142B (en) | Process for preparing 4-amino-pyridazines | |
| PL3325443T3 (pl) | Sposób otrzymywania pridopidyny | |
| ZA201507571B (en) | Process for making 2,5-furandicarboxylic acid | |
| SI3497081T1 (sl) | Postopek za pripravo 4-amonij-2,2,6,6-tetraalkilpiperidinilnih soli | |
| HK1232210A1 (zh) | 製備 -四氯丙烯的方法 | |
| HK1255014A1 (zh) | 製備取代5，6-二氫-6-苯基苯並[f]異喹啉-2-胺的方法 | |
| EP3257855A4 (en) | Method for preparing ibrutinib | |
| IL253877B (en) | Process for the preparation of 3-chloro-2-vinylphenylsulfonates | |
| HK1243708A1 (zh) | 用於製備2-糠酸衍生物的合成方法 | |
| SI2938609T1 (sl) | Postopek za pripravo 1-((1,3)dioksolan-4-ilmetil)-1H-pirazol-3-ilamina | |
| HK1250713A1 (zh) | 製備1-(4-甲磺酰基-2-三氟甲基-苄基)-2-甲基-1h-吡咯並[2，3-b]吡啶-3-基-乙酸的工藝 | |
| PL3160984T3 (pl) | Sposób wytwarzania d-arginylo-2,6-dimetylo-l-tyrozylo-l-lizylol- fenyloalaninoamidu | |
| PL3178803T3 (pl) | Sposób wytwarzania 2,3,3,3-tetrafluoropropenu | |
| GB2540428B (en) | Process for preparing 3,3,3-trifluoropropene | |
| PL3330244T3 (pl) | Sposób produkcji 2,3,3,3-tetrafluoropropenu | |
| IL268765B (en) | Process for preparing 1-(4-methanesulfonyl-2-trifluoromethyl-benzyl)-2-methyl-1h-pyrrolo [2,3-b]pyridin-3-yl-acetic acid | |
| PL3592723T3 (pl) | Sposób wytwarzania 3,3,3-trifluoroprop-1-enu | |
| GB201805255D0 (en) | Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one | |
| IL253830A0 (en) | A process for the preparation of piperidine-4-carbothioamide hydrochloride |